Literature DB >> 35800808

Incidence and Outcomes of Transplant of Infected Donor Corneal Tissues in a Tertiary Hospital in Saudi Arabia.

Ammar Almulhim1, Abdullah F Alnaim2, Ahmed Abdulrazek2, Hammam A Alotaibi2,3.   

Abstract

PURPOSE: The aim of this study is to assess donor rim culture results and predict ocular infections after corneal transplantation to determine the relationship between positive corneoscleral rim cultures and post-keratoplasty infection.
DESIGN: This is a retrospective study.
METHODS: The microbiology results of positive donor rim culture and clinical outcomes of all contaminated grafts at Dhahran Eye Specialist Hospital (DESH) in the Eastern Region of Saudi Arabia between October 2016 and February 2020 were reviewed.
RESULTS: A total of 684 corneal transplantation procedures were performed at DESH during this period. Routine donor rim cultures were done for all cases with six positive cases (0.88%). There were five positive fungal donor rim cultures (0.73%), and one corneal rim was positive for both bacterial and fungal cultures (0.15%). Among these six patients, two patients (33.33%) who received graft positive with candida developed an infection. Both cases required further interventions but were unsuccessful and eventually ended up with re-grafting.
CONCLUSION: In the sample collected, positive fungal contamination was more frequent than bacterial contamination, and the incidence of bacterial infection is relatively low compared to that of fungal infection due to contaminated grafts. Despite the limitations of our study, we support routine corneoscleral rim culture and to start prophylactic antifungal treatment in response to positive donor fungal rim culture.
Copyright © 2022, Almulhim et al.

Entities:  

Keywords:  corneal graft rejection; corneal transplantation; graft contamination; infection; keratoplasty

Year:  2022        PMID: 35800808      PMCID: PMC9244863          DOI: 10.7759/cureus.25514

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

1.  Endophthalmitis after penetrating keratoplasty.

Authors:  Jern Yee Chen; Mark N Jones; Sathish Srinivasan; Timothy J Neal; W John Armitage; Stephen B Kaye
Journal:  Ophthalmology       Date:  2014-09-26       Impact factor: 12.079

2.  The value of routine donor corneal rim cultures in penetrating keratoplasty.

Authors:  S J Wiffen; B C Weston; L J Maguire; W M Bourne
Journal:  Arch Ophthalmol       Date:  1997-06

3.  Incidence and Outcomes of Positive Donor Corneoscleral Rim Fungal Cultures after Keratoplasty.

Authors:  Jesse M Vislisel; Kenneth M Goins; Michael D Wagoner; Gregory A Schmidt; Benjamin T Aldrich; Jessica M Skeie; Cynthia R Reed; M Bridget Zimmerman; Mark A Greiner
Journal:  Ophthalmology       Date:  2016-11-03       Impact factor: 12.079

4.  Association between positive corneal rim cultures and microbiology screening protocols in Ontario.

Authors:  Rahul A Sharma; John S Y Park; Yao Wang; Tinghua Zhang; Linda Sharpen; William Dixon; Rookaya Mather
Journal:  Can J Ophthalmol       Date:  2017-12-01       Impact factor: 1.882

Review 5.  The prognostic role of donor corneoscleral rim cultures in corneal transplantation.

Authors:  Kirk R Wilhelmus; Sohela S Hassan
Journal:  Ophthalmology       Date:  2007-03       Impact factor: 12.079

6.  Microbial Analysis of Donor Corneoscleral Rims and Storage Media.

Authors:  Edmund Tsui; Preston M Luong; Jessa Fogel; Erin S Fogel; Michael E Zegans
Journal:  Ocul Immunol Inflamm       Date:  2018-05-03       Impact factor: 3.070

7.  Outcome of primary adult optical penetrating keratoplasty with imported donor corneas.

Authors:  Michael D Wagoner; El-Sayed Gonnah; Abdul-Elah Al-Towerki
Journal:  Int Ophthalmol       Date:  2009-01-23       Impact factor: 2.031

Review 8.  The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis.

Authors:  Efstathia Kiatos; James J Armstrong; Cindy Ml Hutnik; Stephen M Tsioros; Monali S Malvankar-Mehta; William G Hodge
Journal:  Clinicoecon Outcomes Res       Date:  2017-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.